Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Hodgkin Disease 7Multiple Myeloma 6Leukemia 6Neoplasm Metastasis 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Prostatic Neoplasms 4Neoplasms 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Graft vs Host Disease 4Blast Crisis 4Sarcoma 3Primary Myelofibrosis 3Pancreatic Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Large B-Cell, Diffuse 3Burkitt Lymphoma 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Lung Neoplasms 2

Interventions

Vincristine 1Sirolimus 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vascular Malformations × Sirolimus × Clear all
NCT02110069 2023-09-21

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Boston Children's Hospital

Phase 2 Terminated
4 enrolled 8 charts

Tufted angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Vascular Malformations, Kasabach-Merritt Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡